These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Impact and effectiveness of RotaTeq® vaccine based on 3 years of surveillance following introduction of a rotavirus immunization program in Finland. Vesikari T, Uhari M, Renko M, Hemming M, Salminen M, Torcel-Pagnon L, Bricout H, Simondon F. Pediatr Infect Dis J; 2013 Dec; 32(12):1365-73. PubMed ID: 24051998 [Abstract] [Full Text] [Related]
3. Sustained High Effectiveness of RotaTeq on Hospitalizations Attributable to Rotavirus-Associated Gastroenteritis During 4 Years in Finland. Hemming-Harlo M, Vesikari T, Uhari M, Renko M, Salminen M, Torcel-Pagnon L, Hartwig S, Simondon F, Bricout H. J Pediatric Infect Dis Soc; 2017 Nov 24; 6(4):317-323. PubMed ID: 27760800 [Abstract] [Full Text] [Related]
5. Decrease of Rotavirus Gastroenteritis to a Low Level Without Resurgence for Five Years After Universal RotaTeq Vaccination in Finland. Hemming-Harlo M, Markkula J, Huhti L, Salminen M, Vesikari T. Pediatr Infect Dis J; 2016 Dec 24; 35(12):1304-1308. PubMed ID: 27455440 [Abstract] [Full Text] [Related]
7. The epidemiology of all-cause and rotavirus acute gastroenteritis and the characteristics of rotavirus circulating strains before and after rotavirus vaccine introduction in Yemen: analysis of hospital-based surveillance data. Banajeh SM, Abu-Asba BA. BMC Infect Dis; 2015 Oct 13; 15():418. PubMed ID: 26464210 [Abstract] [Full Text] [Related]
8. Long-term surveillance of rotavirus vaccination after implementation of a national immunization program in Finland (2008-2018). Hemming-Harlo M, Gylling A, Herse F, Haavisto I, Nuutinen M, Pasternack M, Kanibir MN, Hartwig S, Carias C. Vaccine; 2022 Jun 23; 40(29):3942-3947. PubMed ID: 35641360 [Abstract] [Full Text] [Related]
9. Major reduction of rotavirus, but not norovirus, gastroenteritis in children seen in hospital after the introduction of RotaTeq vaccine into the National Immunization Programme in Finland. Hemming M, Räsänen S, Huhti L, Paloniemi M, Salminen M, Vesikari T. Eur J Pediatr; 2013 Jun 23; 172(6):739-46. PubMed ID: 23361964 [Abstract] [Full Text] [Related]
14. Change in incidence of clinic visits for all-cause and rotavirus gastroenteritis in young children following the introduction of universal rotavirus vaccination in Israel. Muhsen K, Chodick G, Goren S, Anis E, Ziv-Baran T, Shalev V, Cohen D. Euro Surveill; 2015 Jun 23; 20(42):. PubMed ID: 26538450 [Abstract] [Full Text] [Related]
18. Predominance of norovirus and sapovirus in Nicaragua after implementation of universal rotavirus vaccination. Bucardo F, Reyes Y, Svensson L, Nordgren J. PLoS One; 2014 Jun 23; 9(5):e98201. PubMed ID: 24849288 [Abstract] [Full Text] [Related]
19. Incidence of rotavirus gastroenteritis hospitalizations and genotypes, before and five years after introducing universal immunization in Israel. Muhsen K, Kassem E, Rubenstein U, Goren S, Ephros M, Cohen D, Shulman LM. Vaccine; 2016 Nov 21; 34(48):5916-5922. PubMed ID: 27771186 [Abstract] [Full Text] [Related]